Ask questions and gain insights about this stock now with Rize AI
TECH logo

Bio-Techne Corporation

TECH

Stock Analysis

$61.86

+0.00 (+0.00%)• Live

Bio-Techne Corporation Analysis Dashboard - Stock Analysis and Financial Metrics

Historical Prices

for Bio-Techne Corporation

Key Financial Metrics

for Bio-Techne Corporation

2024 FY
P/E Ratio
61.60
Revenue Growth
+1.97%
EPS Growth
-40.88%
Market Cap
$8.08B
Dividend Yield
+0.62%
Debt/Equity
0.21
ROIC
+6.66%
FCF Yield
+2.73%
View additional metrics

Valuation

P/B Ratio4.02
EV/Sales6.92

Financial Health

Current Ratio3.71
Return on Assets+10.69%

Analyst Recommendations

for Bio-Techne Corporation

23 analysts
Consensus: Buy

About

for Bio-Techne Corporation

Company Details

for Bio-Techne Corporation

Sector

Healthcare

Industry

Biotechnology

CEO

Kim Kelderman

Employees

3,100

Market Cap

9.74B

Exchange

NASDAQ Global Select

IPO Date

February 9, 1989

CIK

0000842023

ISIN

US09073M1045

CUSIP

09073M104

Country

US

Balance Sheet

for Bio-Techne Corporation

Cash Flow Statement

for Bio-Techne Corporation

Income Statement

for Bio-Techne Corporation

Rize ist ein KI-gestütztes Investment-Research-Terminal, das eine umfassende Aktienanalyse und Einblicke über ein intuitives Dashboard bietet.

News

No news available at the moment.